{"id":683,"date":"2026-02-28T15:11:25","date_gmt":"2026-02-28T15:11:25","guid":{"rendered":"https:\/\/heartcareforyou.in\/blog\/family-history-definition-clinical-context-and-cardiology-overview\/"},"modified":"2026-02-28T15:11:25","modified_gmt":"2026-02-28T15:11:25","slug":"family-history-definition-clinical-context-and-cardiology-overview","status":"publish","type":"post","link":"https:\/\/heartcareforyou.in\/blog\/family-history-definition-clinical-context-and-cardiology-overview\/","title":{"rendered":"Family History: Definition, Clinical Context, and Cardiology Overview"},"content":{"rendered":"\n<h2 class=\"wp-block-heading\">Family History Introduction (What it is)<\/h2>\n\n\n\n<p>Family History is a structured record of health conditions in a patient\u2019s biological relatives.<br\/>\nIt is a clinical history element, not a disease, symptom, or test result by itself.<br\/>\nIn cardiology, it is commonly documented during risk assessment for coronary artery disease, cardiomyopathy, arrhythmias, and sudden cardiac death.<br\/>\nIt helps clinicians decide when inherited or familial cardiovascular conditions should be considered.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Why Family History matters in cardiology (Clinical relevance)<\/h2>\n\n\n\n<p>Family History matters because cardiovascular risk and certain cardiac disorders can cluster in families due to shared genetics, shared environment, or both. In practice, it often functions as an early \u201csignal\u201d that a patient\u2019s baseline probability of disease may differ from the average population, even before symptoms develop.<\/p>\n\n\n\n<p>In cardiology education and clinical reasoning, Family History supports:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Risk stratification<\/strong>: A positive Family History can increase suspicion for atherosclerotic cardiovascular disease (ASCVD), especially when events occurred at younger ages in relatives. It may also modify how clinicians interpret other risk factors such as hypertension, diabetes, tobacco exposure, and lipid abnormalities.<\/li>\n<li><strong>Diagnostic clarity<\/strong>: Inherited cardiomyopathies (for example, hypertrophic cardiomyopathy), channelopathies (for example, long QT syndrome), and familial hypercholesterolemia may first be suspected because of patterns of sudden death, arrhythmias, heart failure, or early myocardial infarction in relatives.<\/li>\n<li><strong>Selection of testing<\/strong>: Family History can influence whether clinicians pursue additional evaluation such as electrocardiography (ECG), echocardiography, ambulatory rhythm monitoring, cardiac magnetic resonance imaging (MRI), lipid testing, or genetic evaluation. Specific choices vary by clinician and case.<\/li>\n<li><strong>Preventive planning<\/strong>: It may prompt earlier or more frequent attention to modifiable risk factors and may shape discussions about lifestyle, screening, and follow-up (educationally and conceptually, not as personal medical advice).<\/li>\n<li><strong>Family-based care<\/strong>: Some cardiovascular diagnoses have implications beyond the individual patient, where identifying an inherited condition can inform evaluation of relatives (\u201ccascade\u201d considerations), depending on protocol and patient factors.<\/li>\n<\/ul>\n\n\n\n<p>Overall, Family History is one of the most accessible tools for connecting population-level epidemiology to the individual patient\u2019s pre-test probability and clinical context.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Classification \/ types \/ variants<\/h2>\n\n\n\n<p>Family History is not classified like a disease stage, but clinicians commonly organize it into practical categories to guide cardiovascular reasoning:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>By degree of relatedness<\/strong><\/li>\n<li><strong>First-degree relatives<\/strong>: parents, siblings, children  <\/li>\n<li><strong>Second-degree relatives<\/strong>: grandparents, aunts\/uncles, nieces\/nephews, half-siblings  <\/li>\n<li>\n<p><strong>Third-degree relatives<\/strong>: cousins, great-grandparents<br\/>\n  Closer relatives generally contribute more to clinical suspicion because they share more genetic material and often similar environments.<\/p>\n<\/li>\n<li>\n<p><strong>By cardiovascular domain<\/strong><\/p>\n<\/li>\n<li><strong>Atherosclerotic disease<\/strong>: myocardial infarction, angina, coronary revascularization, ischemic stroke, peripheral artery disease  <\/li>\n<li><strong>Structural heart disease<\/strong>: cardiomyopathies, congenital heart disease, valvular disease patterns  <\/li>\n<li><strong>Arrhythmia and conduction disorders<\/strong>: atrial fibrillation, pacemaker implantation at a young age, inherited channelopathies  <\/li>\n<li><strong>Aortopathy and vascular syndromes<\/strong>: thoracic aortic aneurysm\/dissection, connective tissue disorder patterns  <\/li>\n<li>\n<p><strong>Metabolic\/lipid disorders<\/strong>: markedly elevated cholesterol patterns consistent with familial dyslipidemias<\/p>\n<\/li>\n<li>\n<p><strong>By pattern of inheritance (when suspected)<\/strong><\/p>\n<\/li>\n<li><strong>Autosomal dominant patterns<\/strong>: often appear across multiple generations, affecting both sexes  <\/li>\n<li><strong>Autosomal recessive patterns<\/strong>: may appear among siblings with unaffected parents  <\/li>\n<li>\n<p><strong>X-linked patterns<\/strong>: sex-linked clustering may be seen<br\/>\n  Many real-world families show <strong>complex (polygenic) inheritance<\/strong> and shared environmental influences, so patterns are not always clear.<\/p>\n<\/li>\n<li>\n<p><strong>By \u201cpremature\u201d vs typical age of onset<\/strong>\n  Clinicians often note whether cardiovascular events occurred at relatively young ages in relatives, because earlier onset can raise suspicion for inherited predisposition. Exact definitions vary by protocol and patient factors.<\/p>\n<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Relevant anatomy &amp; physiology<\/h2>\n\n\n\n<p>Family History does not map to a single anatomic structure, but it is clinically relevant because inherited or familial factors can affect multiple cardiovascular \u201cmodules\u201d:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>\n<p><strong>Coronary circulation and atherosclerosis<\/strong>\n  Genetic and familial influences can shape lipid handling, inflammatory pathways, endothelial function, and propensity for plaque formation in coronary arteries. The physiologic consequence is impaired blood flow to myocardium, which can manifest as ischemia or infarction.<\/p>\n<\/li>\n<li>\n<p><strong>Myocardium (cardiac muscle) and ventricular function<\/strong>\n  Familial cardiomyopathies can alter sarcomere function, cytoskeletal integrity, or myocardial energetics. These changes influence ventricular thickness (hypertrophy), chamber size (dilation), systolic function (ejection performance), and diastolic filling (relaxation and compliance).<\/p>\n<\/li>\n<li>\n<p><strong>Cardiac conduction system<\/strong>\n  Inherited variants in ion channels or conduction tissue development can change depolarization and repolarization, influencing arrhythmia susceptibility. This involves the sinoatrial node, atrioventricular node, His\u2013Purkinje system, and ventricular myocardium electrophysiology.<\/p>\n<\/li>\n<li>\n<p><strong>Valves and outflow tracts<\/strong>\n  Some structural conditions (including certain congenital heart diseases) have familial clustering. Valve function affects forward flow and pressure loading of chambers, influencing remodeling over time.<\/p>\n<\/li>\n<li>\n<p><strong>Aorta and vascular biology<\/strong>\n  Familial aortopathies involve the aortic wall (media and connective tissue), affecting tensile strength and risk of dilation or dissection. Vascular tone and blood pressure regulation also have heritable components that interact with kidney and neurohormonal physiology.<\/p>\n<\/li>\n<\/ul>\n\n\n\n<p>For learners, the key idea is that Family History points toward <em>which cardiovascular structure or physiology might be at risk<\/em>, even before a patient\u2019s own anatomy and function are measured.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Pathophysiology or mechanism<\/h2>\n\n\n\n<p>Family History reflects mechanisms that cluster disease in families. These mechanisms are often overlapping:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>\n<p><strong>Monogenic (single-gene) disorders<\/strong>\n  Some cardiovascular conditions can result primarily from variants in a single gene with relatively higher penetrance. Examples include certain inherited cardiomyopathies, channelopathies, and familial lipid disorders. Even in monogenic disease, expression can vary due to modifier genes and environment.<\/p>\n<\/li>\n<li>\n<p><strong>Polygenic susceptibility<\/strong>\n  Many common outcomes (such as coronary artery disease or hypertension) usually arise from the cumulative effect of many genetic variants, each contributing a small amount of risk. This polygenic background can interact with lifestyle and comorbidities.<\/p>\n<\/li>\n<li>\n<p><strong>Shared environment and behaviors<\/strong>\n  Diet patterns, physical activity norms, tobacco exposure, psychosocial stressors, sleep patterns, and access to healthcare frequently cluster within families. These exposures can amplify or mimic genetic risk.<\/p>\n<\/li>\n<li>\n<p><strong>Gene\u2013environment interaction<\/strong>\n  Familial risk is often not \u201ceither genetics or lifestyle,\u201d but a combined effect. For example, a predisposition to dyslipidemia may lead to earlier atherosclerosis when combined with other exposures.<\/p>\n<\/li>\n<li>\n<p><strong>Ascertainment and detection effects<\/strong>\n  Families with known disease may undergo more screening, increasing detection of asymptomatic disease. Conversely, families with limited healthcare access may have underdiagnosis, making history appear \u201cnegative\u201d despite true risk.<\/p>\n<\/li>\n<\/ul>\n\n\n\n<p>Because these mechanisms vary widely by condition, family structure, and documentation quality, interpretation is probabilistic rather than definitive.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Clinical presentation or indications<\/h2>\n\n\n\n<p>Family History is \u201cused\u201d rather than \u201cpresenting,\u201d but it commonly becomes clinically relevant in scenarios such as:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>A patient with <strong>chest pain or exertional symptoms<\/strong> where early coronary disease in relatives increases suspicion for ischemic etiologies.<\/li>\n<li><strong>Syncope (fainting)<\/strong>, seizures of unclear cause, or palpitations combined with Family History of sudden death or known arrhythmia.<\/li>\n<li><strong>Newly diagnosed cardiomyopathy<\/strong> (dilated, hypertrophic, or arrhythmogenic patterns) where familial disease is possible.<\/li>\n<li><strong>Marked hypercholesterolemia<\/strong> or tendon xanthomas, especially with relatives who had early myocardial infarction.<\/li>\n<li><strong>Unexplained heart failure<\/strong> at a young age or recurrent \u201cviral myocarditis\u201d labels that may mask genetic cardiomyopathy.<\/li>\n<li>A relative with <strong>sudden unexplained death<\/strong>, drowning, single-vehicle accident, or death during sleep\/exertion, raising concern for inherited arrhythmia or cardiomyopathy (interpretation varies by clinician and case).<\/li>\n<li><strong>Thoracic aortic aneurysm\/dissection<\/strong> in the family, prompting attention to heritable aortopathy patterns.<\/li>\n<li><strong>Congenital heart disease<\/strong> in a first-degree relative, which may modestly raise recurrence risk in families depending on the lesion.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Diagnostic evaluation &amp; interpretation<\/h2>\n\n\n\n<p>Evaluating Family History is a core clinical skill. It involves both <em>collection<\/em> and <em>interpretation<\/em>.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">How clinicians collect Family History<\/h3>\n\n\n\n<p>Common approaches include:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Focused cardiovascular Family History questions<\/strong><\/li>\n<li>Heart attack, angina, coronary stents or bypass surgery  <\/li>\n<li>Stroke or transient ischemic attack (TIA)  <\/li>\n<li>Heart failure or cardiomyopathy diagnoses  <\/li>\n<li>Sudden death, unexplained death, or deaths at young ages  <\/li>\n<li>Known arrhythmias (for example, atrial fibrillation), implanted devices (pacemaker\/implantable cardioverter-defibrillator)  <\/li>\n<li>Aortic aneurysm\/dissection  <\/li>\n<li>High cholesterol diagnoses or lipid disorders  <\/li>\n<li>Congenital heart disease and syndromic diagnoses  <\/li>\n<li>\n<p><strong>Degree of relation and lineage<\/strong>\n  Clinicians note whether conditions are on the maternal or paternal side and whether multiple relatives are affected.<\/p>\n<\/li>\n<li>\n<p><strong>Age at diagnosis or event<\/strong>\n  Earlier onset in relatives can increase suspicion for inherited predisposition. Exact \u201cpremature\u201d definitions vary by protocol and patient factors.<\/p>\n<\/li>\n<li>\n<p><strong>Cause of death details<\/strong>\n  \u201cHeart attack\u201d is sometimes used non-specifically; clarifying circumstances (sudden collapse, known coronary disease, heart failure history) can refine interpretation.<\/p>\n<\/li>\n<li>\n<p><strong>Pedigree (family tree)<\/strong>\n  In more complex cases, a three-generation pedigree can help identify inheritance patterns.<\/p>\n<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\">How clinicians interpret Family History<\/h3>\n\n\n\n<p>Interpretation is typically probabilistic:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Clustering of similar phenotypes<\/strong> (for example, multiple relatives with cardiomyopathy) increases concern for inherited disease.<\/li>\n<li><strong>Red flags for inherited conditions<\/strong> may include sudden death at younger ages, recurrent syncope in relatives, multiple relatives with device implantation early in life, or aortic events. The significance depends on the full clinical picture.<\/li>\n<li>\n<p><strong>Absence of Family History does not exclude disease<\/strong>\n  Small families, adoption, estrangement, early non-cardiac deaths, or underdiagnosis can limit sensitivity.<\/p>\n<\/li>\n<li>\n<p><strong>Integration with the patient\u2019s data<\/strong>\n  Family History is interpreted alongside the patient\u2019s symptoms, physical examination, ECG, labs (including lipid profile), and imaging (such as echocardiography). A Family History rarely \u201cdiagnoses\u201d a condition alone.<\/p>\n<\/li>\n<\/ul>\n\n\n\n<p>In some situations, clinicians may consider <strong>genetic counseling and genetic testing<\/strong> or recommend evaluation of relatives, but indications vary by clinician, condition, and local protocol.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Management overview (General approach)<\/h2>\n\n\n\n<p>Family History is not treated directly; it informs the overall care pathway. Management concepts commonly include:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>\n<p><strong>Risk assessment and prevention framework<\/strong>\n  A positive Family History may prompt clinicians to more carefully assess modifiable risk factors (blood pressure, lipids, glycemic status, smoking exposure, weight, physical activity) and to contextualize risk discussions. Specific preventive choices vary by clinician and case.<\/p>\n<\/li>\n<li>\n<p><strong>Targeted screening and surveillance<\/strong>\n  When Family History suggests inherited cardiomyopathy, arrhythmia syndromes, or aortopathy, clinicians may consider targeted testing in the patient (and sometimes relatives). Examples of tools that may be used depending on scenario include:<\/p>\n<\/li>\n<li>\n<p>ECG and ambulatory rhythm monitoring  <\/p>\n<\/li>\n<li>Echocardiography to assess chamber size, wall thickness, systolic\/diastolic function, and valve anatomy  <\/li>\n<li>Cardiac MRI for tissue characterization and detailed morphology in selected cases  <\/li>\n<li>Exercise testing when appropriate for symptoms or risk assessment  <\/li>\n<li>Lipid evaluation and secondary-cause assessment in suspected familial dyslipidemia  <\/li>\n<li>\n<p>Imaging of the aorta when heritable aortic disease is suspected<br\/>\n  The choice, timing, and frequency of testing vary by protocol and patient factors.<\/p>\n<\/li>\n<li>\n<p><strong>Family-based considerations<\/strong>\n  If an inherited condition is diagnosed, clinicians may discuss how relatives could be evaluated (\u201ccascade evaluation\u201d). This often involves coordination among cardiology, primary care, and genetics professionals when available.<\/p>\n<\/li>\n<li>\n<p><strong>Therapeutic implications<\/strong>\n  Family History can influence how urgently clinicians consider certain diagnoses and therapies (for example, lipid-lowering strategies in familial hypercholesterolemia patterns or arrhythmia prevention strategies in channelopathies). Treatment selection depends on the patient\u2019s confirmed diagnosis, severity, comorbidities, and preferences.<\/p>\n<\/li>\n<\/ul>\n\n\n\n<p>This section is necessarily general because Family History affects management indirectly through diagnosis and risk context rather than acting as a standalone condition.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Complications, risks, or limitations<\/h2>\n\n\n\n<p>Family History is low risk to obtain, but there are meaningful limitations and potential pitfalls:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>\n<p><strong>Recall bias and inaccuracies<\/strong>\n  Patients may not know exact diagnoses, ages, or procedures, and family stories can be incomplete or incorrect.<\/p>\n<\/li>\n<li>\n<p><strong>Misclassification of causes of death<\/strong>\n  \u201cHeart attack\u201d may be used to describe sudden death from arrhythmia, stroke, pulmonary embolism, or unknown causes.<\/p>\n<\/li>\n<li>\n<p><strong>Incomplete family structure<\/strong>\n  Adoption, donor conception, estrangement, or small family size can limit interpretability.<\/p>\n<\/li>\n<li>\n<p><strong>Variable penetrance and expressivity<\/strong>\n  Even when a pathogenic genetic variant is present, not all carriers show disease, and severity can differ across relatives.<\/p>\n<\/li>\n<li>\n<p><strong>Over- or underestimation of risk<\/strong>\n  A strong Family History can raise concern, but it does not guarantee disease; conversely, a negative history does not exclude risk.<\/p>\n<\/li>\n<li>\n<p><strong>Psychosocial impact<\/strong>\n  Learning about familial risk can cause anxiety or misunderstanding. Clinicians often aim for clear communication and appropriate referral when needed.<\/p>\n<\/li>\n<li>\n<p><strong>Equity and access issues<\/strong>\n  Differences in healthcare access across generations can influence whether relatives were diagnosed, affecting the \u201cvisibility\u201d of risk.<\/p>\n<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Prognosis &amp; follow-up considerations<\/h2>\n\n\n\n<p>Family History can influence prognosis indirectly by shaping the probability of underlying disease and by prompting earlier recognition. Prognosis in any individual still depends primarily on the <em>patient\u2019s own diagnosis and physiology<\/em> (for example, degree of coronary disease, ventricular function, arrhythmia burden, blood pressure control, and comorbidities).<\/p>\n\n\n\n<p>General follow-up considerations include:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>\n<p><strong>Family History can change over time<\/strong>\n  New diagnoses in relatives may emerge, so clinicians often revisit Family History periodically.<\/p>\n<\/li>\n<li>\n<p><strong>Phenotype matters<\/strong>\n  A Family History of premature coronary disease has different implications than a Family History dominated by cardiomyopathy, sudden death, or aortopathy. The suspected phenotype influences which evaluations are considered.<\/p>\n<\/li>\n<li>\n<p><strong>Earlier recognition may improve planning<\/strong>\n  Identifying inherited conditions can allow anticipatory monitoring and risk discussions, but outcomes vary widely by condition and severity.<\/p>\n<\/li>\n<li>\n<p><strong>Coordination of care<\/strong>\n  Follow-up may involve cardiology, primary care, and sometimes genetics services. The need for multidisciplinary follow-up varies by clinician and case.<\/p>\n<\/li>\n<li>\n<p><strong>Documentation quality supports continuity<\/strong>\n  Clear recording of which relative had what condition and at what age helps future clinicians interpret risk accurately.<\/p>\n<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Family History Common questions (FAQ)<\/h2>\n\n\n\n<p><strong>Q: What does Family History mean in cardiology?<\/strong><br\/>\nFamily History refers to cardiovascular and related conditions diagnosed in a patient\u2019s biological relatives. In cardiology it helps estimate the likelihood of inherited disorders and early-onset atherosclerotic disease. It is one component of a broader risk and diagnostic assessment.<\/p>\n\n\n\n<p><strong>Q: Is a positive Family History the same as having heart disease?<\/strong><br\/>\nNo. A positive Family History indicates higher suspicion or predisposition, but it does not confirm that a person has disease. Diagnosis depends on the individual\u2019s symptoms, exam findings, and tests such as ECG, labs, and imaging.<\/p>\n\n\n\n<p><strong>Q: Which relatives matter most when clinicians ask about Family History?<\/strong><br\/>\nFirst-degree relatives (parents, siblings, children) are often most influential because they share more genetic material and frequently similar environments. Second- and third-degree relatives can still be informative, especially when multiple relatives are affected or when a rare condition is suspected.<\/p>\n\n\n\n<p><strong>Q: Why do clinicians ask about ages and causes of death in relatives?<\/strong><br\/>\nAge at diagnosis or death helps distinguish typical age-related disease from patterns that may suggest inherited predisposition. The circumstances of death also matter because \u201cheart-related\u201d deaths can reflect different mechanisms, including coronary disease, arrhythmia, or structural heart disease. Exact interpretation varies by clinician and case.<\/p>\n\n\n\n<p><strong>Q: What kinds of heart conditions are most associated with strong Family History patterns?<\/strong><br\/>\nExamples include premature coronary artery disease, familial lipid disorders, cardiomyopathies, inherited arrhythmia syndromes, and familial thoracic aortic aneurysm\/dissection. Many common conditions (like hypertension) also cluster in families but usually reflect mixed genetic and environmental influences.<\/p>\n\n\n\n<p><strong>Q: If I don\u2019t know my Family History, does that prevent good care?<\/strong><br\/>\nNot necessarily. Clinicians can still evaluate symptoms and risk using the patient\u2019s own measurements and tests. When Family History is unknown, clinicians may rely more heavily on current risk factors and objective findings.<\/p>\n\n\n\n<p><strong>Q: Does Family History change what tests might be ordered?<\/strong><br\/>\nIt can. For example, a pattern of sudden death or cardiomyopathy in relatives may increase consideration of ECG and echocardiography, while a pattern of early coronary disease may heighten attention to lipid evaluation and other risk markers. The exact testing approach varies by protocol and patient factors.<\/p>\n\n\n\n<p><strong>Q: Can Family History affect activity recommendations or sports participation decisions?<\/strong><br\/>\nIt can contribute to risk discussions when there is concern for inherited cardiomyopathy or arrhythmia syndromes. Decisions about sports clearance or restrictions typically depend on the individual\u2019s evaluation (symptoms, ECG, imaging, and sometimes exercise testing), not Family History alone.<\/p>\n\n\n\n<p><strong>Q: What is \u201cgenetic testing,\u201d and is it always needed when Family History is positive?<\/strong><br\/>\nGenetic testing looks for DNA variants associated with inherited conditions. It is not always needed and is usually most helpful when there is a strong suspicion of a specific inherited disorder or a known familial variant. Whether testing is appropriate varies by clinician and case, and it is often paired with genetic counseling when available.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Family History is a structured record of health conditions in a patient\u2019s biological relatives. It is a clinical history element, not a disease, symptom, or test result by itself. In cardiology, it is commonly documented during risk assessment for coronary artery disease, cardiomyopathy, arrhythmias, and sudden cardiac death. It helps clinicians decide when inherited or familial cardiovascular conditions should be considered.<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-683","post","type-post","status-publish","format-standard","hentry"],"_links":{"self":[{"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/posts\/683","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/comments?post=683"}],"version-history":[{"count":0,"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/posts\/683\/revisions"}],"wp:attachment":[{"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/media?parent=683"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/categories?post=683"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/tags?post=683"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}